Re: 35 years old, you notice! A way of female fertility! "The preservation of fertility" is very important to you!

Female fertility: female fertility is a scarce resource for human reproduction. Eggs are not renewable and can not be repaired after injury. Age is an important factor affecting ovarian function. Women usually enter the decline phase of ovarian function after 30 years old, and enter the rapid decline period at the age of 35. Therefore, women's fertility is best completed before the age of 35, and the quality of eggs will be greatly reduced after that. However, there are always some reasons why we can not give birth to the baby in the ideal time, or to delay the age of childbirth because of social factors, or because of the disease, especially surgery, radiotherapy or chemotherapy, damage the egg, cause premature ovarian failure and be difficult to bear. The conservation of women's fertility is to protect the eggs, embryos or ovarian tissues to reserve hope for children who are healthy in the future.

Dr. Li Mei, affiliated reproductive Hospital of Shandong University, gave a detailed introduction and advice on female fertility preservation: 1 what is fertility conservation? The preservation of female fertility is to prevent future women from encountering infertility problems, and to reserve resources for future fertility. Why do

2 have fertility conservation? The conservation of fertility is to freeze the embryo, egg, or ovarian tissue for the future use of the women who have the risk of fertility loss before they lose or lose their fertility. At present, the risk of fertility loss is mainly due to the need for chemotherapy and radiotherapy of women, mainly malignant tumors.

radiotherapy and chemotherapy as the main stream of cancer treatment, greatly prolongs the survival period of the cancer patients. However, after the cancer is cured, these patients are faced with the sequelae of cancer treatment, including a decline in ovarian function and even premature ovarian failure, in addition to a malignant tumor, due to a variety of connective tissue diseases (such as systemic lupus erythematosus, Behcet's disease, Wegener granuloma, rheumatoid arthritis), and blood system diseases. (for example, aplastic anemia, sickle erythrocytic disease, and recipients of autologous or allogenic bone marrow transplantation), nervous system diseases such as multiple sclerosis, such as multiple sclerosis, and the need for cyclophosphamide, and even the patients receiving radiotherapy, are also faced with risk of premature ovarian failure, that is, fertility loss.

so these young female friends, before carrying out chemotherapy, should carry out the necessary fertility preservation, at least to do the relevant consultation of the conservation of fertility. This has been done very well in foreign countries. In our country, in recent years, more and more attention has been paid to it, and there have been some expert consensus. Women in related needs are good at services and can provide some measures to save fertility. In short, fertility preservation is reproductive insurance, and it is a way to help female friends get pregnancy opportunities. Therefore, in case of need, female friends can choose their own methods of fertility preservation.